Leadership & Management
The triple squeeze on leaders and a messy middle: New future of work report

At a time where the healthcare and life sciences sector is being pushed to reinvent itself, Vanessa Meikle, CEO and Founder of Hunton Executive, delves into the driving force behind a new report: The Future of Work in Healthcare & Life Sciences.
In this candid and reflective podcast, leaders are challenged to re-examine their own assumptions about leadership, workplaces, and the fast-changing dynamics within the sector. Meikle paints an intriguing picture of the complex ecosystem leaders are currently facing that goes far beyond navigating uncertainty.
She reveals key themes from the report including the “triple squeeze” and “messy middle” – not as trends to watch, but as seismic shifts rewriting the rules of leadership and workplace dynamics. She points to one insight in particular that is likely to make leaders uncomfortable.
The report also prompts Meikle to reflect on her own assumptions and biases, especially in relation to artificial intelligence (AI) and the future of work. The findings disrupt familiar thinking, revealing just how easily ingrained ideas can go unchallenged.
If this survey is repeated in two years from now, will leadership and workplaces be a mirror reflecting real change or a mask hiding the status quo?
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics

Philips remote monitoring cuts hospital costs and ICU time by 69%
An innovative remote patient monitoring model has significantly improved post-operative care for patients, cutting ICU hours by 69% and saving […]
MoreNews - MedTech & Diagnostics

VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
VB Spine has officially taken the reins of Stryker’s spinal implants business in Australia and New Zealand. The transition builds […]
MoreNews - Pharmaceuticals

New therapy PBS listed in advanced Parkinson’s disease
A new therapeutic option for advanced Parkinson’s disease, Vyalev (foslevodopa with foscarbidopa), is now listed on the Pharmaceutical Benefits Scheme […]
MoreNews - Pharmaceuticals

PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
From 1 August 2025, two new biosimilars – SteQeyma (ustekinumab) and Omlyclo (omalizumab) – have been listed on the Pharmaceutical […]
More